EP1945665
Meðferðarefni byggð á mótefni sem hafa eflda ADCC virkni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
20.10.2006EP published:
7.12.2011EP application number:
06846120.1
EP translation filed:
23.1.2012Grant published:
15.2.2012EPO information:
European Patent Register
Max expiry date:
19.10.2026Expiry date:
19.10.2019
Title:
ANTIBODY-BASED THERAPEUTICS WITH ENHANCED ADCC ACTIVITY
Timeline
Today
20.10.2006EP application
7.12.2011EP Publication
23.1.2012Translation submitted
15.2.2012Registration published
19.10.2019Expires
Owner
Name:
GENZYME CORPORATIONAddress:
500 Kendall Street, 02142, Cambridge, MA, US
Inventor
Name:
MCPHERSON, John, M.Address:
Hopkinton, MA, US
Name:
EDMUNDS, TimAddress:
Bolton, MA, US
Name:
ZHOU, QunAddress:
Ashland, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
728947 PDate:
21.10.2005Country:
US
Classification
Categories:
C07K 16/00, C07K 16/30, A61K 39/395, A61P 31/00, A61P 35/00, A61P 37/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.9.2012
Expires: 19.10.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 10.9.2013
Expires: 19.10.2014
Payer: Árnason Faktor
Number: 9
Paid: 9.9.2014
Expires: 19.10.2015
Payer: Árnason Faktor
Number: 10
Paid: 10.9.2015
Expires: 19.10.2016
Payer: Árnason Faktor
Number: 11
Paid: 6.9.2016
Expires: 19.10.2017
Payer: Árnason Faktor
Number: 12
Paid: 11.9.2017
Expires: 19.10.2018
Payer: Árnason Faktor
Number: 13
Paid: 6.9.2018
Expires: 19.10.2019
Payer: Árnason Faktor